Researching and developing therapeutic products for human use.
SEBI has halted Par Drugs and Chemicals' proposed slump sale of its core business to Phal-Jig Fine Chemicals, a promoter-related entity, citing irregularities in valuation and shareholder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results